Antimicrobial susceptibility of Brucella melitensis in Kazakhstan

Alexandr Shevtsov, Marat Syzdykov, Andrey Kuznetsov, Alexandr Shustov, Elena Shevtsova, Kalysh Berdimuratova, Kasim Mukanov, Yerlan Ramankulov

Research output: Contribution to journalArticle

Abstract

Background: Kazakhstan belongs to countries with a high level of brucellosis among humans and farm animals. Although antibiotic therapy is the main way to treat acute brucellosis in humans there is still little information on a circulation of the antibiotic-resistant Brucella strains in the Central Eurasia. In this article we describe an occurrence of the drug resistance of Brucella melitensis isolates in Kazakhstan which is among the largest countries of the region. Methods: Susceptibilities to tetracyclin, gentamycin, doxycyclin, streptomycin and rifampicin were investigated in 329 clinical isolates of Brucella melitensis using E-test method. Results: All isolates were susceptible to streptomycin, tetracycline and doxycycline. 97.3% of the Brucella isolates were susceptible to gentamycin, although only 37.4% of isolates were susceptible to rifampicin. 21.9% of isolates had intermediate resistance, and 26.4% of isolates were resistant to this antibacterial drug. Conclusion: Isolates of Brucella melitensis circulating in Kazakhstan are susceptible to streptomycin, doxicyclin, tetracyclin and gentamycin. At the same time the resistance to rifampicin is widespread, almost half of the isolates were rifampicin-resistant (including the intermediate resistance).

Original languageEnglish
Article number130
JournalAntimicrobial Resistance and Infection Control
Volume6
Issue number1
DOIs
Publication statusPublished - Dec 28 2017

Fingerprint

Kazakhstan
Brucella melitensis
Rifampin
Streptomycin
Gentamicins
Brucella
Brucellosis
Anti-Bacterial Agents
Doxycycline
Domestic Animals
Tetracycline
Drug Resistance
Pharmaceutical Preparations

Keywords

  • Antimicrobial susceptibility
  • Brucella melitensis
  • Kazakhstan

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Antimicrobial susceptibility of Brucella melitensis in Kazakhstan. / Shevtsov, Alexandr; Syzdykov, Marat; Kuznetsov, Andrey; Shustov, Alexandr; Shevtsova, Elena; Berdimuratova, Kalysh; Mukanov, Kasim; Ramankulov, Yerlan.

In: Antimicrobial Resistance and Infection Control, Vol. 6, No. 1, 130, 28.12.2017.

Research output: Contribution to journalArticle

Shevtsov, A, Syzdykov, M, Kuznetsov, A, Shustov, A, Shevtsova, E, Berdimuratova, K, Mukanov, K & Ramankulov, Y 2017, 'Antimicrobial susceptibility of Brucella melitensis in Kazakhstan', Antimicrobial Resistance and Infection Control, vol. 6, no. 1, 130. https://doi.org/10.1186/s13756-017-0293-x
Shevtsov A, Syzdykov M, Kuznetsov A, Shustov A, Shevtsova E, Berdimuratova K et al. Antimicrobial susceptibility of Brucella melitensis in Kazakhstan. Antimicrobial Resistance and Infection Control. 2017 Dec 28;6(1). 130. https://doi.org/10.1186/s13756-017-0293-x
Shevtsov, Alexandr ; Syzdykov, Marat ; Kuznetsov, Andrey ; Shustov, Alexandr ; Shevtsova, Elena ; Berdimuratova, Kalysh ; Mukanov, Kasim ; Ramankulov, Yerlan. / Antimicrobial susceptibility of Brucella melitensis in Kazakhstan. In: Antimicrobial Resistance and Infection Control. 2017 ; Vol. 6, No. 1.
@article{b06c984768a64bdb826f96ad959ea729,
title = "Antimicrobial susceptibility of Brucella melitensis in Kazakhstan",
abstract = "Background: Kazakhstan belongs to countries with a high level of brucellosis among humans and farm animals. Although antibiotic therapy is the main way to treat acute brucellosis in humans there is still little information on a circulation of the antibiotic-resistant Brucella strains in the Central Eurasia. In this article we describe an occurrence of the drug resistance of Brucella melitensis isolates in Kazakhstan which is among the largest countries of the region. Methods: Susceptibilities to tetracyclin, gentamycin, doxycyclin, streptomycin and rifampicin were investigated in 329 clinical isolates of Brucella melitensis using E-test method. Results: All isolates were susceptible to streptomycin, tetracycline and doxycycline. 97.3{\%} of the Brucella isolates were susceptible to gentamycin, although only 37.4{\%} of isolates were susceptible to rifampicin. 21.9{\%} of isolates had intermediate resistance, and 26.4{\%} of isolates were resistant to this antibacterial drug. Conclusion: Isolates of Brucella melitensis circulating in Kazakhstan are susceptible to streptomycin, doxicyclin, tetracyclin and gentamycin. At the same time the resistance to rifampicin is widespread, almost half of the isolates were rifampicin-resistant (including the intermediate resistance).",
keywords = "Antimicrobial susceptibility, Brucella melitensis, Kazakhstan",
author = "Alexandr Shevtsov and Marat Syzdykov and Andrey Kuznetsov and Alexandr Shustov and Elena Shevtsova and Kalysh Berdimuratova and Kasim Mukanov and Yerlan Ramankulov",
year = "2017",
month = "12",
day = "28",
doi = "10.1186/s13756-017-0293-x",
language = "English",
volume = "6",
journal = "Antimicrobial Resistance and Infection Control",
issn = "2047-2994",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Antimicrobial susceptibility of Brucella melitensis in Kazakhstan

AU - Shevtsov, Alexandr

AU - Syzdykov, Marat

AU - Kuznetsov, Andrey

AU - Shustov, Alexandr

AU - Shevtsova, Elena

AU - Berdimuratova, Kalysh

AU - Mukanov, Kasim

AU - Ramankulov, Yerlan

PY - 2017/12/28

Y1 - 2017/12/28

N2 - Background: Kazakhstan belongs to countries with a high level of brucellosis among humans and farm animals. Although antibiotic therapy is the main way to treat acute brucellosis in humans there is still little information on a circulation of the antibiotic-resistant Brucella strains in the Central Eurasia. In this article we describe an occurrence of the drug resistance of Brucella melitensis isolates in Kazakhstan which is among the largest countries of the region. Methods: Susceptibilities to tetracyclin, gentamycin, doxycyclin, streptomycin and rifampicin were investigated in 329 clinical isolates of Brucella melitensis using E-test method. Results: All isolates were susceptible to streptomycin, tetracycline and doxycycline. 97.3% of the Brucella isolates were susceptible to gentamycin, although only 37.4% of isolates were susceptible to rifampicin. 21.9% of isolates had intermediate resistance, and 26.4% of isolates were resistant to this antibacterial drug. Conclusion: Isolates of Brucella melitensis circulating in Kazakhstan are susceptible to streptomycin, doxicyclin, tetracyclin and gentamycin. At the same time the resistance to rifampicin is widespread, almost half of the isolates were rifampicin-resistant (including the intermediate resistance).

AB - Background: Kazakhstan belongs to countries with a high level of brucellosis among humans and farm animals. Although antibiotic therapy is the main way to treat acute brucellosis in humans there is still little information on a circulation of the antibiotic-resistant Brucella strains in the Central Eurasia. In this article we describe an occurrence of the drug resistance of Brucella melitensis isolates in Kazakhstan which is among the largest countries of the region. Methods: Susceptibilities to tetracyclin, gentamycin, doxycyclin, streptomycin and rifampicin were investigated in 329 clinical isolates of Brucella melitensis using E-test method. Results: All isolates were susceptible to streptomycin, tetracycline and doxycycline. 97.3% of the Brucella isolates were susceptible to gentamycin, although only 37.4% of isolates were susceptible to rifampicin. 21.9% of isolates had intermediate resistance, and 26.4% of isolates were resistant to this antibacterial drug. Conclusion: Isolates of Brucella melitensis circulating in Kazakhstan are susceptible to streptomycin, doxicyclin, tetracyclin and gentamycin. At the same time the resistance to rifampicin is widespread, almost half of the isolates were rifampicin-resistant (including the intermediate resistance).

KW - Antimicrobial susceptibility

KW - Brucella melitensis

KW - Kazakhstan

UR - http://www.scopus.com/inward/record.url?scp=85039555995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039555995&partnerID=8YFLogxK

U2 - 10.1186/s13756-017-0293-x

DO - 10.1186/s13756-017-0293-x

M3 - Article

AN - SCOPUS:85039555995

VL - 6

JO - Antimicrobial Resistance and Infection Control

JF - Antimicrobial Resistance and Infection Control

SN - 2047-2994

IS - 1

M1 - 130

ER -